Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 27 for “"Essential thrombocythemia"”.

  1. Analysis of essential thrombocythemia and its treatment

    Essential thrombocythemia (ET) is a rare myeloproliferative neoplasm affecting 43.7 out of every 100,000 people in the United States. The disease is characterized by abnormally high platelet counts, mutational abnormalities in Janus Kinase 2 (JAK2)/Calreticulin (CALR)/myeloproliferative leukemia …

    bu Repository record for Analysis of essential thrombocythemia and its treatment (opens in a new tab)

  2. EVALUATION OF ASPIRIN RESPONSIVENESS IN ESSENTIAL THROMBOCYTHEMIA PATIENTS

    Background. Essential thrombocythemia (ET) is characterized by an increased number of platelets, associated with risk for both bleeding and thrombotic complications. Prophylaxis with 100 mg acetylsalicylic acid (ASA) is indicated in patients at risk. A significant proportion of ET patients (ETs) …

    milano Repository record for EVALUATION OF ASPIRIN RESPONSIVENESS IN ESSENTIAL THROMBOCYTHEMIA PATIENTS (opens in a new tab)

  3. ANAGRELIDE E FATTORE DI CRESCITA FIBROBLASTICO-2 (FGF-2) NELLA TROMBOCITEMIA ESSENZIALE

    … and fibroblast growth factor-2 levels in essential thrombocythemia, anagrelide and fibroblast growth factor-2 levels in patientswith essential thrombocythemia, abnormal production of interleukin (IL)-6 in essential thrombocythemia, janus kinase V617F mutation and inflammatory interleukins …

    catania Repository record for ANAGRELIDE E FATTORE DI CRESCITA FIBROBLASTICO-2 (FGF-2) NELLA TROMBOCITEMIA ESSENZIALE (opens in a new tab)

  4. Quantification Of Cerebral Blood Flow In Mouse Models Of Hematological Disease

    … confirmation in animal models of the diseases-essential thrombocythemia and polycythemia vera, specifically. We found cerebral microvessels in the subjects to be largely occluded by leukocytes and platelets, which adhered tightly to the endothelium. In the case of essential thrombocythemia, …

    cornell Repository record for Quantification Of Cerebral Blood Flow In Mouse Models Of Hematological Disease (opens in a new tab)

  5. Η μελέτη του γονιδίου JAK2 στα μυελοϋπερπλαστικά και άλλα σύνδρομα όσον αφορά το φορτίο νόσου και τη σχέση γονοτύπου/φαινοτύπου

    … incidence and response to therapy. Patients with essential thrombocythemia often complain of various subjective neurological symptoms. Among thirty-seven consecutive patients with essential thrombocythemia, 11 presented with neurological symptoms. Brain magnetic resonance imagery failed to detect …

    greece Repository record for Η μελέτη του γονιδίου JAK2 στα μυελοϋπερπλαστικά και άλλα σύνδρομα όσον αφορά το φορτίο νόσου και τη σχέση γονοτύπου/φαινοτύπου (opens in a new tab)

  6. Διαταραχές αιμόστασης σε μυελοϋπερπλαστικά νοσήματα

    … (PN-MPN) such as polycythemia vera (PV), essential thrombocythemia (ET) and myelofibrosis (MF), are at a higher risk for venous thrombosis. Thromboelastometry may prove more efficient than conventional hemostatic laboratory tests to evaluate the patient’s thrombotic risk.In this study, …

    greece Repository record for Διαταραχές αιμόστασης σε μυελοϋπερπλαστικά νοσήματα (opens in a new tab)

  7. Μελέτη λειτουργικότητας των αιμοπεταλίων στην ιδιοπαθή θρομβοκυτταραιμία

    … crucial component of all diagnostic criteria for essential thrombocythemia (ET) has been the exclusion of reactive thrombocytosis (RT). Our aim was to evaluate the diagnostic performance of the PFA-100 collagen-epinephrine (CEPI) cartridge test and epinephrine-induced aggregometry individually, …

    greece Repository record for Μελέτη λειτουργικότητας των αιμοπεταλίων στην ιδιοπαθή θρομβοκυτταραιμία (opens in a new tab)

  8. Μοριακή μελέτη της παθογένειας των χρόνιων μυελοϋπερπλαστικών συνδρόμων

    … diseases which include polycythemia vera (PV), essential thrombocythemia (ET), and myelofibrosis (MF). The discovery of recurrent molecular abnormalities such as JAK2V617F and MPL W515L/K has reinforced the original idea of Dameshek in 1951 that these diseases share a common pathogenetic …

    greece Repository record for Μοριακή μελέτη της παθογένειας των χρόνιων μυελοϋπερπλαστικών συνδρόμων (opens in a new tab)

  9. THE GENETIC REGULATION OF THE RESPONSE OF HEMATOPOIETIC STEM/PROGENITOR CELLS TO THE CYTOSTATIC AGENT HYDROXYUREA

    … disorders, such as chronic myelogenous leukemia, essential thrombocythemia, and polycythemia vera. It should come as no surprise then, that common treatments for these diseases often target the proliferative nature of the dysfunctional HSC/HPCs. Thus, the identification of molecular determinants …

    uky-thes Repository record for THE GENETIC REGULATION OF THE RESPONSE OF HEMATOPOIETIC STEM/PROGENITOR CELLS TO THE CYTOSTATIC AGENT HYDROXYUREA (opens in a new tab)

  10. Understanding the crosstalk between MPN stem and progenitor cells and the bone marrow niche

    … cells. These neoplasms, comprised of Essential Thrombocythemia (ET), Polycythaemia Vera (PV) and Primary Myelofibrosis (PMF), often present JAK2V617F mutation and they are accompanied by chronic bone marrow (BM) inflammation, although the source of inflammation is still unclear (Mendez …

    kings Repository record for Understanding the crosstalk between MPN stem and progenitor cells and the bone marrow niche (opens in a new tab) Download PDF for Understanding the crosstalk between MPN stem and progenitor cells and the bone marrow niche (opens in a new tab)

  11. Φλεγμονή και θρομβωτικά επεισόδια σε ασθενείς με κλασικά μυελοϋπερπλαστικά νοσήματα: Νεότερα δεδομένα και θεραπευτικές δυνατότητες

    … vera, PV), την ιδιοπαθή θρομβοκυττάρωση (essential thrombocythemia, ET) και την πρωτοπαθή μυελοίνωση (primary myelofibrosis, PMF). Η κλασική μετάλλαξη JAK2V617F χαρακτηρίζει τη πλειοψηφία των ασθενών με PV, και μικρότερα ποσοστά των ασθενών με ΕΤ και PMF, με δευτερεύουσες τις μεταλλάξεις …

    athens Repository record for Φλεγμονή και θρομβωτικά επεισόδια σε ασθενείς με κλασικά μυελοϋπερπλαστικά νοσήματα: Νεότερα δεδομένα και θεραπευτικές δυνατότητες (opens in a new tab)

  12. Risk factors in the occurrence and diagnosis of myeloid neoplasms

    … conferred a small potential increase in risk of essential thrombocythemia (ET), PMF, and other myeloproliferative neoplasms. However, it is difficult to determine whether autoimmune disorders increased the risk of MN, or whether the small elevation in the effect estimate was an artifact of …

    bu Repository record for Risk factors in the occurrence and diagnosis of myeloid neoplasms (opens in a new tab)

  13. The Mevalonate Pathway: A Potential Therapeutic Target for JAK2-driven Myeloproliferative Neoplasms

    … classical MPNs, including polycythemia vera, essential thrombocythemia, and myelofibrosis, are diseases of dysregulated JAK2 signaling. In fact, the majority of MPN patients have activating mutations in JAK2 (e.g JAK2-V617F), a tyrosine kinase that contributes to the growth and survival of …

    usf Repository record for The Mevalonate Pathway: A Potential Therapeutic Target for JAK2-driven Myeloproliferative Neoplasms (opens in a new tab)

  14. Elucidating metabolic alterations in myeloproliferative neoplasms: implications for treatment

    … three phenotypes namely Polycythaemia Vera (PV), Essential Thrombocythemia (ET) and Primary Myelofibrosis (PMF). The three main somatic mutations leading to MPN are Janus Kinase 2 V617F (JAK2V617F), Janus Kinase 2 exon 12 and Calreticulin (CALR). JAK2V617F was the first driver mutation found in …

    glasgow Repository record for Elucidating metabolic alterations in myeloproliferative neoplasms: implications for treatment (opens in a new tab) Download PDF for Elucidating metabolic alterations in myeloproliferative neoplasms: implications for treatment (opens in a new tab)

  15. New molecular and cellular aspects of mutant calreticulin in Myeloproliferative Neoplasms

    … Mutations in CALR exon 9 have been identified in essential thrombocythemia and primary myelofibrosis, two myeloproliferative neoplasms (MPNs) characterised by megakaryocyte hyperplasia. Despite the large body of research built around CALR mutations, many aspects of the oncogenic mechanisms of CALR …

    salford Download PDF for New molecular and cellular aspects of mutant calreticulin in Myeloproliferative Neoplasms (opens in a new tab)

  16. Ringsingsideroblastische Anämien in Assoziation mit Thrombozytosen : ein heterogenes Krankheitsspektrum

    Die Assoziation einer Thrombozytose mit einer RS stellt ein seltenes Krankheitsbild dar, welches sowohl Kennzeichen eines MDS als auch eines MPD besitzt. In der aktuellen WHO-Klassifikation gilt diese sogenannte ET/RS deshalb als nicht eindeutig zu klassifizierende Erkrankung. Untersuchungen an …

    freiburg-diss Repository record for Ringsingsideroblastische Anämien in Assoziation mit Thrombozytosen : ein heterogenes Krankheitsspektrum (opens in a new tab)

  17. Die Rolle des Transkriptionsfaktors NF-E2 in der Entstehung der Erythrozytose und Thrombozytose myeloproliferativer Erkrankungen

    Die myeloproliferativen Erkrankungen (MPD) Polyzythämia Vera (PV), Essentielle Thrombozythämie (ET) und Primäre Myelofibrose (PMF) sind durch eine deregulierte klonale Expansion reifer Blutzellen gekennzeichnet. Dies führt zu thrombotischen Ereignissen, Minderdurchblutung bei hyperviskosem Blut und …

    freiburg-diss Repository record for Die Rolle des Transkriptionsfaktors NF-E2 in der Entstehung der Erythrozytose und Thrombozytose myeloproliferativer Erkrankungen (opens in a new tab)

Page 1 of 2